5JA1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sprint Bioscience AB

Watchlist Manager

Watchlist

Price: 0.222 EUR -0.45% Market Closed

Market Cap: €15.5m

	Sprint Bioscience AB F:5JA1	SE
C	Chorus Ltd SWB:7CH	NZ
	UOB-Kay Hian Holdings Ltd SGX:U10	SG
	Perusahaan Gas Negara Tbk PT OTC:PPAAF	ID
	British Land Company PLC LSE:BLND	UK
R	Resilient Reit Ltd JSE:RES	ZA
K	Kingfisher PLC XMUN:KFI1	UK
	Marchex Inc NASDAQ:MCHX	US
U	UDR Inc F:UF0	US

Profitability Summary

Sprint Bioscience AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

73%

Gross Margin is Increasing

-15 956% > 94%

Exceptional Operating Margin

57%

Negative 3Y Average Operating Margin

-6%

Operating Margin is Increasing

-85 811% > 57%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-6%

Net Margin is Increasing

-85 364% > 55%

Exceptional Free Cash Flow Margin

46%

Negative 3Y Average Free Cash Flow Margin

-3%

Free Cash Flow Margin is Increasing

-71 910% > 46%

Exceptional ROE

154%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

69%

ROIC is Increasing

-1 142% > 933%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.